Register for Upcoming Webinar on DEC. 8 @ 11AM

2024 China NMPA Bluebook is here:

CFDA Update: Actions Taken to Deepen Registration Reform

Share:

In this month, CFDA released three documents for public comment:

1) Policies on Reforming Clinical Trial Management for Encouraging Pharmaceutical and Medical Device Innovation.
2) Policies on Accelerating Review and Approval Process for Encouraging Pharmaceutical and Medical Device Innovation.
3) Polices on Implementing Full Life-Cycle Management for Encouraging Pharmaceutical and Medical Device Innovation.

According to the CFDA, these three documents aim to further deepen registration reform, promote industrial upgrade and innovation in the pharmaceutical and medical device sector, and meet increasing clinical needs.

Contact China Med Device (CMD) team if you would like to know more about CFDA’s registration and policy reform and get immediate help to accelerate your device’s market entry in China. Please call us 978-390-4453 or email info@ChinaMedDevice.com.

Have Questions?

Related Services

Resources

Recent Events

Related Posts

Search

Get Updated

Receive Updates in Your Inbox

Categories

Archives